Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Talanta ; 256: 124299, 2023 May 01.
Article in English | MEDLINE | ID: covidwho-2183606

ABSTRACT

The objective of this work was to evaluate the use of an electronic nose and chemometric analysis to discriminate global patterns of volatile organic compounds (VOCs) in breath of postCOVID syndrome patients with pulmonary sequelae. A cross-sectional study was performed in two groups, the group 1 were subjects recovered from COVID-19 without lung damage and the group 2 were subjects recovered from COVID-19 with impaired lung function. The VOCs analysis was executed using a Cyranose 320 electronic nose with 32 sensors, applying principal component analysis (PCA), Partial Least Square-Discriminant Analysis, random forest, canonical discriminant analysis (CAP) and the diagnostic power of the test was evaluated using the ROC (Receiver Operating Characteristic) curve. A total of 228 participants were obtained, for the postCOVID group there are 157 and 71 for the control group, the chemometric analysis results indicate in the PCA an 84% explanation of the variability between the groups, the PLS-DA indicates an observable separation between the groups and 10 sensors related to this separation, by random forest, a classification error was obtained for the control group of 0.090 and for the postCOVID group of 0.088 correct classification. The CAP model showed 83.8% of correct classification and the external validation of the model showed 80.1% of correct classification. Sensitivity and specificity reached 88.9% (73.9%-96.9%) and 96.9% (83.7%-99.9%) respectively. It is considered that this technology can be used to establish the starting point in the evaluation of lung damage in postCOVID patients with pulmonary sequelae.


Subject(s)
COVID-19 , Volatile Organic Compounds , Humans , Cross-Sectional Studies , Breath Tests/methods , COVID-19/diagnosis , Lung/chemistry , Sensitivity and Specificity , Exhalation , Electronic Nose , Volatile Organic Compounds/analysis
2.
Glob Public Health ; 16(7): 975-999, 2021 07.
Article in English | MEDLINE | ID: covidwho-1221434

ABSTRACT

Latin America and the Caribbean (LAC) was declared a new epicentre of the coronavirus pandemic by the World Health Organization (WHO) on 22 May 2020. As of 13 January 2021, the numbers of deaths and cases caused by COVID-19 in LAC reported are 552,000 and 17'485,000 respectively. LAC concentrates the largest percentage of indigenous populations throughout the world. In this region, poverty is persistent and particularly rural indigenous peoples hold the steepest barriers to health services and experience profound discrimination based on ethnicity, poverty, and language, compared to their non-indigenous counterparts. The information regarding the health of indigenous populations, in general, is scarce, and this problem is aggravated in the face of the COVID-19 pandemic. Therefore, the main objective of this work is to address the overall scenario of indigenous peoples in the Latin American and Caribbean region from March 2020 to January 2021, in this manner gathering information regarding health problems, economic, social, cultural and environmental factors that make indigenous populations in LAC particularly vulnerable to serious health effects from the COVID-19 pandemic, as well as compiling the mitigation strategies implemented in indigenous communities.


Subject(s)
COVID-19/epidemiology , Health Services Accessibility , Indigenous Peoples , Pneumonia, Viral/epidemiology , Caribbean Region/epidemiology , Humans , Latin America/epidemiology , Pandemics , Pneumonia, Viral/virology , Poverty Areas , Risk Factors , SARS-CoV-2 , Vulnerable Populations
SELECTION OF CITATIONS
SEARCH DETAIL